Skip to main content
Top
Gepubliceerd in: Quality of Life Research 8/2013

01-10-2013

Validation of a new quality of life scale related to multiple sclerosis and relapses

Auteurs: Antoine Baroin, Gilles Chopard, Gaye Siliman, Clément Michoudet, Aurore Vivot, Chrystelle Vidal, Hassna Mokadym, Annick Lavier, Ėric Berger, Lucien Rumbach, Nathalie Rude

Gepubliceerd in: Quality of Life Research | Uitgave 8/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Multiple sclerosis (MS) has a significant impact on all aspects of patient quality of life (QoL). Furthermore, the fear of relapses and the feelings of patients during relapses must be taken into account in care. The objective of this work was to validate the PERSEPP scale (“PERception de la Sclérose En Plaques et de ses Poussées”), a new QoL evaluation scale for relapsing–remitting forms of MS.

Methods

Relapsing–remitting patients were included in a multicenter study. Various validation criteria of this scale were analyzed: acceptability, construct validity (internal and external validity), and reliability (internal consistency and reproducibility test–retest). Responsiveness will be studied in order to complete the validation process.

Results

The responses of 305 MS patients were analyzed. The process of reducing the items led us to retain 66 items of a total of 112 items. The 66-item PERSEPP scale (final version) was well accepted. Five dimensions (33 items) make up the scale: social support (α = 0.81), relationship difficulties (α = 0.71), fatigue (α = 0.74), state of mind and associated sleep disorders (α = 0.78), and time perspective (α = 0.75). Three additional modules (33 items) explore coping (α = 0.60), symptoms (α = 0.89), and treatment (α = 0.92). Test–retest reliability, measured by the intraclass correlation coefficient (ICC), was acceptable (0.72 < ICC < 0.92).

Conclusions

The PERSEPP scale has been validated and could be used in clinical trials and in daily practice. Additional studies will then complete the validation process.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Siepman, T. A., Janssens, A. C., de Koning, I., Polman, C. H., Boringa, J. B., & Hintzen, R. Q. (2008). The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. Journal of Neurology, 255(6), 910–916.PubMedCrossRef Siepman, T. A., Janssens, A. C., de Koning, I., Polman, C. H., Boringa, J. B., & Hintzen, R. Q. (2008). The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. Journal of Neurology, 255(6), 910–916.PubMedCrossRef
2.
go back to reference Penner, I. K., Bechtel, N., Raselli, C., Stöcklin, M., Opwis, K., Kappos, L., et al. (2007). Fatigue in multiple sclerosis: Relation to depression, physical impairment, personality and action control. Multiple Sclerosis, 13(9), 1161–1167.PubMedCrossRef Penner, I. K., Bechtel, N., Raselli, C., Stöcklin, M., Opwis, K., Kappos, L., et al. (2007). Fatigue in multiple sclerosis: Relation to depression, physical impairment, personality and action control. Multiple Sclerosis, 13(9), 1161–1167.PubMedCrossRef
3.
go back to reference Solari, A. (2005). Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health and Quality of Life Outcomes, 3, 16.PubMedCrossRef Solari, A. (2005). Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health and Quality of Life Outcomes, 3, 16.PubMedCrossRef
4.
go back to reference Clavelou, P., Auclair, C., Taithe, F., & Gerbaud, L. (2009). Quality of life in multiple sclerosis: Theoretical and practical aspects. Revue Neurologique, 165(2), F115–F124.PubMed Clavelou, P., Auclair, C., Taithe, F., & Gerbaud, L. (2009). Quality of life in multiple sclerosis: Theoretical and practical aspects. Revue Neurologique, 165(2), F115–F124.PubMed
5.
go back to reference Riazi, A., Porter, B., Chataway, J., Thompson, A. J., & Hobart, J. C. (2011). A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: The Multiple Sclerosis Relapse Management Scale (MSRMS). Health and Quality of Life Outcomes, 9, 80.PubMedCrossRef Riazi, A., Porter, B., Chataway, J., Thompson, A. J., & Hobart, J. C. (2011). A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: The Multiple Sclerosis Relapse Management Scale (MSRMS). Health and Quality of Life Outcomes, 9, 80.PubMedCrossRef
6.
go back to reference Vernay, D., Gerbaud, L., Biolay, S., Coste, J., Debourse, J., Aufauvre, D., et al. (2000). Quality of life and multiple sclerosis: Validation of the French version of the self-questionnaire (SEP-59). Revue Neurologique, 156(3), 247–263.PubMed Vernay, D., Gerbaud, L., Biolay, S., Coste, J., Debourse, J., Aufauvre, D., et al. (2000). Quality of life and multiple sclerosis: Validation of the French version of the self-questionnaire (SEP-59). Revue Neurologique, 156(3), 247–263.PubMed
7.
go back to reference Baumstarck-Barrau, K., Pelletier, J., Simeoni, M.-C., Auquier, P., & the MusiQol Study Group. (2011). French validation of the Multiple Sclerosis International Quality of Life Questionnaire. Revista de Neurologia, 167(6–7), 511–521.CrossRef Baumstarck-Barrau, K., Pelletier, J., Simeoni, M.-C., Auquier, P., & the MusiQol Study Group. (2011). French validation of the Multiple Sclerosis International Quality of Life Questionnaire. Revista de Neurologia, 167(6–7), 511–521.CrossRef
8.
go back to reference McKenna, S. P., Doward, L. C., Twiss, J., Hagell, P., Oprandi, N. C., Fisk, J., et al. (2010). International development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS). Value Health, 13(8), 946–951.PubMedCrossRef McKenna, S. P., Doward, L. C., Twiss, J., Hagell, P., Oprandi, N. C., Fisk, J., et al. (2010). International development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS). Value Health, 13(8), 946–951.PubMedCrossRef
9.
go back to reference Hirst, C., Ingram, G., Pearson, O., Pickersgill, T., Scolding, N., & Robertson, N. (2008). Contribution of relapses to disability in multiple sclerosis. Journal of Neurology, 255(2), 280–287.PubMedCrossRef Hirst, C., Ingram, G., Pearson, O., Pickersgill, T., Scolding, N., & Robertson, N. (2008). Contribution of relapses to disability in multiple sclerosis. Journal of Neurology, 255(2), 280–287.PubMedCrossRef
10.
go back to reference Ozakbas, S., Cagiran, I., Ormeci, B., & Idiman, E. (2004). Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Journal of the Neurological Sciences, 218(1–2), 3–7.PubMedCrossRef Ozakbas, S., Cagiran, I., Ormeci, B., & Idiman, E. (2004). Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Journal of the Neurological Sciences, 218(1–2), 3–7.PubMedCrossRef
11.
go back to reference Halper, J. (2007). The psychosocial effect of multiple sclerosis: The impact of relapses. Journal of the Neurological Sciences, 256(1), S34–S38.PubMedCrossRef Halper, J. (2007). The psychosocial effect of multiple sclerosis: The impact of relapses. Journal of the Neurological Sciences, 256(1), S34–S38.PubMedCrossRef
12.
go back to reference Kalb, R. (2007). The emotional and psychological impact of multiple sclerosis relapses. Journal of the Neurological Sciences, 256(1), S29–S33.PubMedCrossRef Kalb, R. (2007). The emotional and psychological impact of multiple sclerosis relapses. Journal of the Neurological Sciences, 256(1), S29–S33.PubMedCrossRef
13.
go back to reference Baroin, A., Chopard, G., Mokadym, H., Lavier, A., Berger, E., Rumbach, L., et al. (2010). Establishing a quality of life scale related to relapses in multiple sclerosis. 62nd annual meeting of American Academy of Neurology, Toronto. Neurology, 74(2), A160. Baroin, A., Chopard, G., Mokadym, H., Lavier, A., Berger, E., Rumbach, L., et al. (2010). Establishing a quality of life scale related to relapses in multiple sclerosis. 62nd annual meeting of American Academy of Neurology, Toronto. Neurology, 74(2), A160.
14.
go back to reference Baroin, A., Mokadym, H., Chopard, G., Lavier, A., Berger, E., Rumbach, L., et al. (2012). Establishing an evaluation scale for the perception of quality of life related to relapsing-remitting forms of multiple sclerosis and feasibility study. International Journal of Neuroscience, 122(1), 9–16.PubMedCrossRef Baroin, A., Mokadym, H., Chopard, G., Lavier, A., Berger, E., Rumbach, L., et al. (2012). Establishing an evaluation scale for the perception of quality of life related to relapsing-remitting forms of multiple sclerosis and feasibility study. International Journal of Neuroscience, 122(1), 9–16.PubMedCrossRef
15.
go back to reference Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452.PubMedCrossRef Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452.PubMedCrossRef
16.
go back to reference Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., et al. (1998). Cross-validation of item selection and scoring for the SF-12 health survey in Nine Countries: Results from the IQOLA project. Journal of Clinical Epidemiology, 51(11), 1171–1178.PubMedCrossRef Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., et al. (1998). Cross-validation of item selection and scoring for the SF-12 health survey in Nine Countries: Results from the IQOLA project. Journal of Clinical Epidemiology, 51(11), 1171–1178.PubMedCrossRef
17.
go back to reference Radat, F., Lafittau, M., Ouallet, J. C., Brochet, B., & Jouvent, R. (2007). Validation of EHD self questionnaire in multiple sclerosis. Encephale, 33(1), 49–57.PubMedCrossRef Radat, F., Lafittau, M., Ouallet, J. C., Brochet, B., & Jouvent, R. (2007). Validation of EHD self questionnaire in multiple sclerosis. Encephale, 33(1), 49–57.PubMedCrossRef
18.
go back to reference Simeoni, M.-C., Auquier, P., Fernandez, O., Flachenecker, P., Stecchi, S., Constantinescu, C. S., et al. (2008). Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis, 14(2), 219–230.PubMedCrossRef Simeoni, M.-C., Auquier, P., Fernandez, O., Flachenecker, P., Stecchi, S., Constantinescu, C. S., et al. (2008). Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis, 14(2), 219–230.PubMedCrossRef
19.
go back to reference Falissard, B. (2001). Mesurer la subjectivité en santé. Perspective méthodologique et statistique (p. 211). Paris: Masson. Falissard, B. (2001). Mesurer la subjectivité en santé. Perspective méthodologique et statistique (p. 211). Paris: Masson.
20.
go back to reference Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory. New York: McGraw-Hill. Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory. New York: McGraw-Hill.
21.
go back to reference Sébille, V., Hardouin, J.-B., Le Néel, T., Kubis, G., Boyer, F., Guillemin, F., et al. (2010). Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients—a simulation study. BMC Medical Research Methodology, 10, 24.PubMedCrossRef Sébille, V., Hardouin, J.-B., Le Néel, T., Kubis, G., Boyer, F., Guillemin, F., et al. (2010). Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients—a simulation study. BMC Medical Research Methodology, 10, 24.PubMedCrossRef
22.
go back to reference Prieto, L., Alonso, J., & Lamarca, R. (2003). Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health and Quality of Life Outcomes, 1, 27.PubMedCrossRef Prieto, L., Alonso, J., & Lamarca, R. (2003). Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health and Quality of Life Outcomes, 1, 27.PubMedCrossRef
23.
go back to reference Penta, M., Arnould, C., & Decruynaere, C. (2005). Développer et interpréter une échelle de mesure. Applications du modèle de Rasch (p. 186). Sprimont: Mardaga. Penta, M., Arnould, C., & Decruynaere, C. (2005). Développer et interpréter une échelle de mesure. Applications du modèle de Rasch (p. 186). Sprimont: Mardaga.
24.
go back to reference Ramp, M., Khan, F., Misajon, R. A., & Pallant, J. F. (2009). Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29). Health and Quality of Life Outcomes, 7, 58.PubMedCrossRef Ramp, M., Khan, F., Misajon, R. A., & Pallant, J. F. (2009). Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29). Health and Quality of Life Outcomes, 7, 58.PubMedCrossRef
25.
go back to reference Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef
26.
go back to reference Andrich, D., Sheridan, B. E., & Luo G. (2010). RUMM2030 (Rasch Unidimensional Measurement Model version 5.1) [Computer software]. Perth, Western Australia: RUMM Laboratory. Andrich, D., Sheridan, B. E., & Luo G. (2010). RUMM2030 (Rasch Unidimensional Measurement Model version 5.1) [Computer software]. Perth, Western Australia: RUMM Laboratory.
27.
go back to reference Rummel, R. J. (1970). Applied factor analysis. Evanston, IL: Northwestern University Press. Rummel, R. J. (1970). Applied factor analysis. Evanston, IL: Northwestern University Press.
28.
go back to reference Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81–105.PubMedCrossRef Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81–105.PubMedCrossRef
29.
go back to reference Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86(2), 420–428.PubMedCrossRef Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86(2), 420–428.PubMedCrossRef
30.
go back to reference Béthoux, F. (2006). Fatigue and multiple sclerosis. Annales de Réadaptation et de Médecine Physique, 49(6), 265–271.PubMedCrossRef Béthoux, F. (2006). Fatigue and multiple sclerosis. Annales de Réadaptation et de Médecine Physique, 49(6), 265–271.PubMedCrossRef
31.
go back to reference Préau, M., Apostolidis, T., François, C., Raffi, F., & Spire, B. (2007). Time perspective and quality of life among HIV-infected patients in the context of HAART. AIDS Care, 19(4), 449–458.PubMedCrossRef Préau, M., Apostolidis, T., François, C., Raffi, F., & Spire, B. (2007). Time perspective and quality of life among HIV-infected patients in the context of HAART. AIDS Care, 19(4), 449–458.PubMedCrossRef
32.
go back to reference Zimbardo, P. G., & Boyd, J. N. (1999). Putting time in perspective: A valid, reliable individual-differences metric. Journal of Personality and Social Psychology, 77, 1271–1288.CrossRef Zimbardo, P. G., & Boyd, J. N. (1999). Putting time in perspective: A valid, reliable individual-differences metric. Journal of Personality and Social Psychology, 77, 1271–1288.CrossRef
33.
go back to reference Montel, S. R., & Bungener, C. (2007). Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis. Multiple Sclerosis, 13(3), 393–401.PubMedCrossRef Montel, S. R., & Bungener, C. (2007). Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis. Multiple Sclerosis, 13(3), 393–401.PubMedCrossRef
34.
go back to reference Moreau, T., Schmidt, N., Joyeux, O., Bungener, C., & Souvignet, V. (2009). Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatment. European Neurology, 62(2), 79–85.PubMedCrossRef Moreau, T., Schmidt, N., Joyeux, O., Bungener, C., & Souvignet, V. (2009). Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatment. European Neurology, 62(2), 79–85.PubMedCrossRef
35.
go back to reference Doward, L. C., McKenna, S. P., Meads, D. M., Twiss, J., & Eckert, B. J. (2009). The development of patient-reported outcome indices for multiple sclerosis (PRIMUS). Multiple Sclerosis, 15(9), 1092–1102.PubMedCrossRef Doward, L. C., McKenna, S. P., Meads, D. M., Twiss, J., & Eckert, B. J. (2009). The development of patient-reported outcome indices for multiple sclerosis (PRIMUS). Multiple Sclerosis, 15(9), 1092–1102.PubMedCrossRef
36.
go back to reference Twiss, J., Doward, L. C., McKenna, S. P., & Eckert, B. (2010). Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS). Health and Quality of Life Outcomes, 8, 117.PubMedCrossRef Twiss, J., Doward, L. C., McKenna, S. P., & Eckert, B. (2010). Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS). Health and Quality of Life Outcomes, 8, 117.PubMedCrossRef
37.
go back to reference Buljevac, D., Hop, W. C. J., Reedeker, W., Janssens, A. C. J. W., van der Meché, F. G. A., van Doorn, P. A., et al. (2003). Self reported stressful life events and exacerbations in multiple sclerosis: Prospective study. BMJ, 327(7416), 646.PubMedCrossRef Buljevac, D., Hop, W. C. J., Reedeker, W., Janssens, A. C. J. W., van der Meché, F. G. A., van Doorn, P. A., et al. (2003). Self reported stressful life events and exacerbations in multiple sclerosis: Prospective study. BMJ, 327(7416), 646.PubMedCrossRef
Metagegevens
Titel
Validation of a new quality of life scale related to multiple sclerosis and relapses
Auteurs
Antoine Baroin
Gilles Chopard
Gaye Siliman
Clément Michoudet
Aurore Vivot
Chrystelle Vidal
Hassna Mokadym
Annick Lavier
Ėric Berger
Lucien Rumbach
Nathalie Rude
Publicatiedatum
01-10-2013
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 8/2013
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-012-0334-0

Andere artikelen Uitgave 8/2013

Quality of Life Research 8/2013 Naar de uitgave